CDK4/6 Inhibitor Priming Enhances PD‐1 Blockade via Sell hi Neutrophil‐Induced Stat5a + Progenitor Exhausted CD8 + T Cell
Advanced Science · 2025
DOI: 10.1002/advs.202510501 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Yu Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Maxillofacial and Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shan…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6, Neutrophils. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Young Elite Scientist Sponsorship Program by CAST.
Abstract (Originalsprache)
Cell cycle pathway, especially via cyclin D1‐CDK4/6 signaling, is enriched in immunotherapy‐resistant and immune‐excluded tumors. CDK4/6 inhibitor (CDK4/6i) induces antitumor immune phenotypes by targeting both tumor and immune cells, enhancing immune checkpoint blockade (ICB), but optimal combination modalities and the corresponding cellular mechanisms remain unclear. Here, it is shown that activation of tumor cell‐intrinsic cyclin D1‐CDK4/6 signaling is associated with low tumor‐infiltrating lymphocyte populations and immunotherapy resistance in head and neck squamous cell carcinoma (HNSCC). Comparison of sequential versus combinatorial regimens in subcutaneous or orthotopic HNSCC mice revealed that CDK4/6i priming before anti‐PD‐1 enhances response durability by promoting CD8 + and CD4 + T cell infiltration and decreasing overall neutrophil abundance. Mechanistically, IL15‐secreted Sell(hi) neutrophils induced Stat5a+ progenitor exhausted CD8 + T cells contributed to the antitumor effect of CDK4/6i priming modalities. Together with corroborating evidence from a clinically relevant patient‐derived‐organoid‐TIL (PDO‐TIL) co‐culture model, these findings support further clinical testing of brief CDK4/6i dosing before anti‐PD‐1 to improve ICB efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Maxillofacial and Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.
- College of Stomatology, Shanghai Jiao Tong University, Shanghai, 200011, China.
- National Center for Stomatology, Shanghai, 200011, China.
- National Clinical Research Center for Oral Diseases, Shanghai, 200011, China.
- Shanghai Key Laboratory of Stomatology, Shanghai, 200011, China.
- State Key Laboratory Cultivation Base of Research, Prevention and Treatment for Oral Diseases, Nanjing Medical University, Nanjing, 210029, China.
ORCID-Profile: Ziyue Gu
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Young Elite Scientist Sponsorship Program by CAST
- Clinical Research Plan of SHDC
- Shanghai "Rising Stars of Medical Talents" Youth Development Program
- China Postdoctoral Science Foundation
Zitieren
APA
Zhang, Y., Sun, B., Zhou, R., Gong, Z., Han, Y., Tao, W., Shi, C., Zhang, W., Liu, L., Zhang, Z., Li, J., Zhu, Q., Zhu, W., & Gu, Z. (2025). CDK4/6 Inhibitor Priming Enhances PD‐1 Blockade via Sell hi Neutrophil‐Induced Stat5a + Progenitor Exhausted CD8 + T Cell. Advanced Science. https://doi.org/10.1002/advs.202510501
Vancouver
Zhang Y, Sun B, Zhou R, Gong Z, Han Y, Tao W, et al. CDK4/6 Inhibitor Priming Enhances PD‐1 Blockade via Sell hi Neutrophil‐Induced Stat5a + Progenitor Exhausted CD8 + T Cell. Advanced Science. 2025. doi:10.1002/advs.202510501
BibTeX
@article{Zhang2025,
author = {Zhang, Yu and Sun, Bao and Zhou, Rong and Gong, Zizhen and Han, Yong and Tao, Wenjie and Shi, Chaoji and Zhang, Wuchang and Liu, Laikui and Zhang, Zhiyuan and Li, Jiang and Zhu, Qi and Zhu, Weiwen and Gu, Ziyue},
title = {CDK4/6 Inhibitor Priming Enhances PD‐1 Blockade via Sell hi Neutrophil‐Induced Stat5a + Progenitor Exhausted CD8 + T Cell},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202510501}
}
EUVIMED